Royal Bank of Canada’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-10
| Closed | – | – | 7435 |
|
2023
Q1 | $0 | Buy |
10
+6
| +150% | – | ﹤0.01% | 7272 |
|
2022
Q4 | $0 | Sell |
4
-4
| -50% | – | ﹤0.01% | 7502 |
|
2022
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 7573 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 6772 |
|
2020
Q3 | – | Sell |
-66
| Closed | -$9K | – | 6501 |
|
2020
Q2 | $9K | Hold |
66
| – | – | ﹤0.01% | 5404 |
|
2020
Q1 | $3K | Buy |
66
+7
| +12% | +$318 | ﹤0.01% | 5733 |
|
2019
Q4 | $7K | Sell |
59
-1
| -2% | -$119 | ﹤0.01% | 5665 |
|
2019
Q3 | $7K | Buy |
60
+2
| +3% | +$233 | ﹤0.01% | 5287 |
|
2019
Q2 | $17K | Hold |
58
| – | – | ﹤0.01% | 5014 |
|
2019
Q1 | $26K | Buy |
58
+44
| +314% | +$19.7K | ﹤0.01% | 4797 |
|
2018
Q4 | $6K | Buy |
+14
| New | +$6K | ﹤0.01% | 5287 |
|
2018
Q3 | – | Sell |
-75
| Closed | -$44K | – | 6358 |
|
2018
Q2 | $44K | Buy |
75
+53
| +241% | +$31.1K | ﹤0.01% | 4634 |
|
2018
Q1 | $14K | Buy |
+22
| New | +$14K | ﹤0.01% | 4992 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 6158 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 6207 |
|